Skip to main navigation

Search for:

Skip to content

Main Navigation

News & Media
Publications
Join Us
Contact
Blog
Search

About Us
Approach
Platform & Pipeline
Patients & Caregivers
Medical Professionals
Investors

News Releases

Year

March 23, 2023

Vor Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update

Read More

February 21, 2023

Vor Bio to Participate in Upcoming Investor Conferences

Read More

February 16, 2023

First AML Patient Transplanted with Vor Bio’s Trem-cel Demonstrated Durable Engraftment through Multiple Mylotarg™ Cycles at Initial Dose Level

Read More

January 19, 2023

Vor Bio to Present Clinical Data from First Patient Treated with Trem-cel at 2023 Tandem Meetings

Read More

January 12, 2023

Vor Bio to Present at B. Riley Securities’ 3rd Annual Oncology Conference

Read More

Shareholder Tools

Print Page

RSS

Email Alerts

Contact IR

Search

Follow us on social media:

Twitter LinkedIn

About Us
Approach
Platform & Pipeline
- Our Platform
- Our Pipeline
Patients & Caregivers
Medical Professionals
- Our Investigational Program
- Clinical Trials
Investors
News & Media
Publications
Join Us
Blog

© 2022 Vor Biopharma

Privacy Policy
Terms of Use